Blood Factor Contamination Cases
Result: Confidential settlements
Year: 2009
Blood Factor VIII and Factor IX Litigation
Working with counsel in Asia, Europe, Central and South America and the Middle East, Lieff Cabraser represented over 1500 of hemophiliacs worldwide, or their survivors and estates, who contracted HIV and/or Hepatitis C (HCV), and Americans with hemophilia who contracted HCV, from contaminated and defective blood factor products produced by American pharmaceutical companies. In 2004, Lieff Cabraser was appointed Plaintiffs’ Lead Counsel of the “second generation” Blood Factor MDL litigation presided over by Judge Grady in the Northern District of Illinois. The case reached a global settlement in 2009.
Civil Litigation News
San Francisco Schools Receive Financial Boost From Settlement With JUUL
As reported by the S.F. Chronicle, the San Francisco Unified School District has been awarded a substantial $24.65 million payment from vaping
Final Approval Granted to Historic $235M Settlement with Altria in National JUUL Youth E-Cigarette Predatory Advertising, Addiction and Injury Litigation
On March 14, 2024, U.S. District Judge William Orrick of the Northern District of California issued an order granting final approval to a comprehensive
New York Times Spotlights Lieff Cabraser’s Recent Win on Behalf of Hawaiian Kona Coffee Farmers
The New York Times has published an exemplary piece highlighting Lieff Cabraser’s leadership in securing a pivotal victory for Kona coffee farmers
